The board of directors of AbbVie Inc. (NYSE:ABBV) declared a quarterly cash dividend of $1.07 per share. The cash dividend is payable August 15, 2019 to stockholders of record at the close of business on July 15, 2019. Since the company’s inception in 2013, AbbVie has increased its dividend by 168 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
Technical Stock Analysis
AbbVie Inc. (NYSE:ABBV), a Healthcare sector firm, traded 10.5 Million shares in last trading session and stock added 0.56% with closing price of $78.78 per share. Company gross margins represents its total sales revenue minus its cost of goods sold (COGS), divided by the total sales revenue earned by the company, expressed as a percentage. And its good to know that the higher that percentage, the more the company retains on each dollar of sales, to service its other costs and the debt obligations, and AbbVie Inc. (NYSE:ABBV)’s gross margin stands at 77.30%.
Investment Worthy Stock or not?
For personal guess ROI is usually expressed as a percentage and is typically used for taking any financial decisions, for the purpose of comparing a AbbVie Inc. (NYSE:ABBV)’s profitability or to compare the efficiency of different investments, hence, ABBV return on investment (ROI) is 21.80%.
52-Week Range are valuable stats for watching AbbVie Inc. (NYSE:ABBV)’s past year fluctuation as that gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range. AbbVie Inc. (NYSE:ABBV)’s stock value has moved between $73.63 – 99.72 in last one year.
Analysts mean target price for AbbVie Inc. (NYSE:ABBV) is $90.07 while analysts mean recommendation is 2.90.
Its weekly performance is 0.11% while year to date (YTD) performance is -14.55%.
Earnings per share growth is defined as the percentage change in normalised earnings per share over the previous 12 month period to the latest year end. It gives a good picture of the rate at which a company has grown its profitability. AbbVie Inc. (NYSE:ABBV)’s EPS growth this year is 4.80%. For best decision making investors should look at AbbVie Inc. (NYSE:ABBV)’s EPS growth for next year stands at 7.67%.